Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder CarcinomaEmil Christensen, Lars Dyrskjøt, Ramya Srinivasan et al.|Journal of Clinical Oncology|2019Cited by 540
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|Nature Communications|2021Cited by 381
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Lars Dyrskjøt, Emil Christensen et al.|Nature Communications|2020Cited by 216
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder CancerTrine Strandgaard, Lars Dyrskjøt, Sia V. Lindskrog et al.|European Urology|2022Cited by 74
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen, Lars Dyrskjøt, Iver Nordentoft et al.|Clinical Cancer Research|2023Cited by 73